Viewing Study NCT06345976



Ignite Creation Date: 2024-05-06 @ 8:21 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06345976
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-03
First Post: 2024-03-28

Brief Title: Functional Impairment in Albinism
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Organization: Fondation Ophtalmologique Adolphe de Rothschild

Study Overview

Official Title: Functional Impairment in Albinism
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PLAIB
Brief Summary: Albinism is a genetic and hereditary anomaly that affects pigmentation This pathology is characterized by a deficit in melanin production In humans the clinical diagnosis of albinism is based on a number of factors including

In the integumentary region fair skin tone with white hair eyelashes and eyebrows
Ophthalmological reduced visual acuity photophobia nystagmus transilluminated blue irises hypopigmentation of the retina at the back of the eye with fovea plana

As treatment options begin to emerge for certain albinism-induced anomalies including for example the depigmentation that causes photophobia it is desirable to understand what these patients complaints are and to gather their views on the emergence of treatments targeting just one of their complaints namely glare
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None